Emergent BioSolutions Inc. (0IGA.L)
| Previous close | 1.9200 |
| Open | 2.9200 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 2.8380 - 4.7520 |
| 52-week range | 1.4800 - 13.4182 |
| Volume | |
| Avg. volume | 19,429 |
| Market cap | 1.736M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 0.01 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript
Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript May 1, 2024 Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $0.59, expectations were $-0.86. Emergent BioSolutions Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone. I’m […]
- GuruFocus.com
Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...
Emergent BioSolutions Inc (EBS) showcases robust revenue growth and operational efficiency in the first quarter of 2024.
- Reuters
PRESS DIGEST- Wall Street Journal - May 2
The following are the top stories in the Wall Street Journal. - Microsoft will invest $2.2 billion in cloud and artificial-intelligence infrastructure in Malaysia. - Federal Reserve Chair Jerome Powell tried to keep the central bank's options open on Wednesday by sticking with his view that interest rates are restrictive and that inflation was likely to resume its decline.
